Company intelligence / Profile preview

Qing Lan

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Qinglan Biotech is a Chinese biotechnology company specializing in the development of innovative microneedle drug delivery systems. The company focuses on transdermal delivery of vaccines, proteins, and small molecules using its proprietary soluble microneedle platform. Their technology aims to provide painless, efficient, and stable alternatives to traditional injections, targeting applications in dermatology, metabolic diseases, and immunization. Beyond medical applications, the company also commercializes microneedle-based products for the aesthetics and skincare markets.

Therapeutic areas: Infectious DiseasesEndocrinologyDermatology
Modalities: Microneedle drug delivery therapySmall moleculeBiologicVaccine
Industry: Biotech

Beyond the preview

Go deeper on Qing Lan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qing Lan.

Explore the full profile